Nexalin Technology (NXL) Amortizatization of Intangibles (2023 - 2026)
Nexalin Technology's (NXL) quarterly Amortizatization of Intangibles came in at $6736.0 in Q1 2026, up 40.74% year-on-year from $4786.0 in Q1 2025, and up 9.49% quarter-over-quarter from $6152.0 in Q4 2025.
Nexalin Technology (NXL) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Nexalin Technology's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $6736.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 40.74% year-over-year to $6736.0 in Q1 2026; TTM through Mar 2026 was $23486.0, a 36.3% increase from a year earlier, with the FY2025 full-year figure at $21537.0, up 42.56% from the prior year.
- Amortizatization of Intangibles advanced to $6736.0 in Q1 2026 per NXL's latest filing, from $6152.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $6736.0 in Q1 2026 and bottomed at $660.0 in Q1 2023.
- The 4-year median for Amortizatization of Intangibles is $4211.0 (2024), against an average of $3625.4.
- Across the five-year window, Amortizatization of Intangibles surged 459.23% in 2024 and advanced 29.97% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $1646.0 in 2023, then jumped by 169.81% to $4441.0 in 2024, then jumped by 38.53% to $6152.0 in 2025, then advanced by 9.49% to $6736.0 in 2026.
- Per Business Quant, the three latest NXL Amortizatization of Intangibles figures stand at $6736.0 (Q1 2026), $6152.0 (Q4 2025), and $5473.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Nexalin Technology | 9.07 Mn | 6.36 Mn | 13,133.00 | 6,736.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,736.00 |
| Mar 31, 2026 | 6,736.00 |
| Dec 31, 2025 | 6,152.00 |
| Dec 31, 2025 | 6,152.00 |
| Sep 30, 2025 | 5,473.00 |
| Sep 30, 2025 | 5,473.00 |
| Jun 30, 2025 | 5,125.00 |
| Jun 30, 2025 | 5,125.00 |
| Mar 31, 2025 | 4,786.00 |
| Mar 31, 2025 | 4,786.00 |
| Dec 31, 2024 | 4,441.00 |
| Dec 31, 2024 | 4,441.00 |
| Sep 30, 2024 | 4,211.00 |
| Sep 30, 2024 | 4,211.00 |
| Jun 30, 2024 | 3,793.00 |
| Jun 30, 2024 | 3,793.00 |
| Mar 31, 2024 | 2,662.00 |
| Mar 31, 2024 | 2,662.00 |
| Dec 31, 2023 | 1,646.00 |
| Dec 31, 2023 | 1,646.00 |